The researchers then looked at maternal outcomes. "I think this is where the news is extraordinary. ... Our mild-moderate flair rate was 18%, which we were obviously very excited about," Dr. Buyon said. Only 15 patients had a severe flare-up, and most flares did not require medication.
The study was funded by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Dr. Buyon reported that she has no relevant financial disclosures.